Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML)

Added 64 days ago (22.07.2021)
Authors: Hardikkumar Jetani; Almudena Navarro-Bailón; Marius Maucher; Silke Frenz; Christina Mathilde Verbruggen; Ana Yeguas; María-Belén Vidriales; Marcos González; Judit Rial Saborido; Sabrina Kraus; Katrin Mestermann; Simone Thomas; Halvard Bonig; Maik Luu; Razieh Monjezi; Dimitrios Mougiakakos; Markus Sauer; Hermann Einsele; Michael Hudecek
Journal: Blood
Read article